Jae Yong Park

8.6k total citations
248 papers, 4.9k citations indexed

About

Jae Yong Park is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jae Yong Park has authored 248 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Molecular Biology, 90 papers in Pulmonary and Respiratory Medicine and 58 papers in Oncology. Recurrent topics in Jae Yong Park's work include RNA modifications and cancer (45 papers), Lung Cancer Treatments and Mutations (39 papers) and Epigenetics and DNA Methylation (34 papers). Jae Yong Park is often cited by papers focused on RNA modifications and cancer (45 papers), Lung Cancer Treatments and Mutations (39 papers) and Epigenetics and DNA Methylation (34 papers). Jae Yong Park collaborates with scholars based in South Korea, China and United States. Jae Yong Park's co-authors include Chang Ho Kim, Tae Hoon Jung, Jin Eun Choi, Won Kee Lee, Dong Sun Kim, Shin Yup Lee, Sin Kam, Seung Ick, Seung Soo Yoo and Sung Ick and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Jae Yong Park

233 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jae Yong Park South Korea 38 3.0k 1.3k 1.2k 1.1k 422 248 4.9k
Rosario Caltabiano Italy 38 2.1k 0.7× 1.3k 1.0× 705 0.6× 688 0.6× 336 0.8× 283 5.2k
Rafael López‐López Spain 35 1.8k 0.6× 1.7k 1.3× 2.2k 1.8× 934 0.8× 334 0.8× 242 4.5k
Shinya Kimura Japan 45 2.6k 0.9× 683 0.5× 2.1k 1.7× 1.1k 1.0× 464 1.1× 427 7.1k
Byeong‐Cheol Ahn South Korea 42 2.8k 0.9× 1.3k 1.0× 912 0.7× 624 0.6× 230 0.5× 274 6.6k
Corrado Rubini Italy 40 2.4k 0.8× 997 0.8× 1.7k 1.4× 660 0.6× 514 1.2× 261 6.2k
Paavo Pääkkö Finland 47 2.5k 0.8× 1.1k 0.9× 1.8k 1.4× 2.2k 2.0× 325 0.8× 148 6.2k
Andrea Nicolini Italy 38 1.4k 0.5× 1.1k 0.8× 2.0k 1.6× 751 0.7× 416 1.0× 166 5.0k
Roeland Hanemaaijer Netherlands 49 2.0k 0.7× 2.1k 1.6× 1.4k 1.2× 1.2k 1.1× 218 0.5× 104 6.4k
Dongsheng Zhang China 35 1.9k 0.7× 1.2k 0.9× 825 0.7× 530 0.5× 192 0.5× 187 4.3k
Pier Paolo Claudio United States 39 2.7k 0.9× 690 0.5× 2.0k 1.7× 429 0.4× 408 1.0× 175 5.1k

Countries citing papers authored by Jae Yong Park

Since Specialization
Citations

This map shows the geographic impact of Jae Yong Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jae Yong Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jae Yong Park more than expected).

Fields of papers citing papers by Jae Yong Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jae Yong Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jae Yong Park. The network helps show where Jae Yong Park may publish in the future.

Co-authorship network of co-authors of Jae Yong Park

This figure shows the co-authorship network connecting the top 25 collaborators of Jae Yong Park. A scholar is included among the top collaborators of Jae Yong Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jae Yong Park. Jae Yong Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cui, Minghua, Quanzhu Chen, Nan Wang, et al.. (2024). Single Nucleotide Polymorphism. PubMed. 12(8). 927–927.
2.
3.
Choi, Jin Eun, Hyo Sung Jeon, Ji Yoon Lee, et al.. (2023). Epigenetic and genetic inactivation of tumor suppressor miR‐135a in non‐small‐cell lung cancer. Thoracic Cancer. 14(11). 1012–1020. 3 indexed citations
4.
Yoo, Seung Soo, S. Lee, Jin Eun Choi, et al.. (2023). Promoter-Specific Variants in NeuroD1 and H3K4me3 Coincident Regions and Clinical Outcomes of Small Cell Lung Cancer. Journal of Korean Medical Science. 38(45). e381–e381. 2 indexed citations
5.
Kim, Chang Ho, Sang Yub Lee, Yong Hoon Lee, et al.. (2019). Differential diagnosis between lymphoma-associated malignant pleural effusion and tuberculous pleural effusion. Annals of Translational Medicine. 7(16). 373–373. 11 indexed citations
6.
Seok, Yangki, Shin Yup Lee, Ji Yun Jeong, et al.. (2017). Polymorphisms in Epithelial-Mesenchymal Transition-Related Genes and the Prognosis of Surgically Treated Non-small Cell Lung Cancer. Annals of Surgical Oncology. 24(11). 3386–3395. 6 indexed citations
7.
Lee, Shin Yup, Jin Eun Choi, Won Kee Lee, et al.. (2016). Polymorphisms in cancer-related pathway genes and lung cancer. European Respiratory Journal. 48(4). 1184–1191. 6 indexed citations
8.
Lee, So-Yeon, Jin Eun Choi, Eungbae Lee, et al.. (2016). The Different Effect ofVEGFPolymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology. Journal of Korean Medical Science. 31(11). 1735–1735. 7 indexed citations
9.
Lee, Shin Yup, Hyo‐Sung Jeon, Ji Yun Jeong, et al.. (2013). The influence ofTP53mutations on the prognosis of patients with early stage non-small cell lung cancer may depend on the intratumor heterogeneity of the mutations. Molecular Carcinogenesis. 54(2). 93–101. 19 indexed citations
10.
Jeon, Hyo-Sung, Guang Jin, Yi Young Choi, et al.. (2013). A Functional Variant at 19q13.3, rs967591G>A, Is Associated with Shorter Survival of Early-Stage Lung Cancer. Clinical Cancer Research. 19(15). 4185–4195. 14 indexed citations
11.
Jang, Jin Sung, Hyo-Sung Jeon, Zhifu Sun, et al.. (2012). Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers. Clinical Cancer Research. 18(13). 3658–3667. 91 indexed citations
12.
Choi, Jin Eun, Hyo‐Gyoung Kang, Jin Sung Jang, et al.. (2009). Polymorphisms in Telomere Maintenance Genes and Risk of Lung Cancer. Cancer Epidemiology Biomarkers & Prevention. 18(10). 2773–2781. 53 indexed citations
13.
Kim, Dong Sun, Mi Jin Kim, Ji Yun Lee, et al.. (2009). Epigenetic inactivation of checkpoint kinase 2 gene in non-small cell lung cancer and its relationship with clinicopathological features. Lung Cancer. 65(2). 247–250. 23 indexed citations
14.
Chae, Myung Hwa, Kyung Mee Kim, Eung Bae Lee, et al.. (2007). EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients. Cancer Genetics and Cytogenetics. 173(2). 107–113. 67 indexed citations
15.
Chae, Myung Hwa, Won Kee Lee, Sung Ick, et al.. (2007). Identification of polymorphisms in the XIAP gene and analysis of association with lung cancer risk in a Korean population. Cancer Genetics and Cytogenetics. 180(1). 6–13. 7 indexed citations
16.
Lee, Seung Jun, Eun Jin Kim, Seung Ick, et al.. (2007). A case of pulmonary mucormycosis complicated by pneumomediastinum and subcutaneous emphysema after chemotherapy in a patient with small cell lung cancer. The Korean Journal of Internal Medicine. 72(5). 551–557. 1 indexed citations
17.
Choi, Yi Young, Jin Eun Choi, Jin Sung Jang, et al.. (2007). Comprehensive assessment of P21 polymorphisms and lung cancer risk. Journal of Human Genetics. 53(1). 87–95. 20 indexed citations
18.
Chae, Myung Hwa, Jung Min Park, Jung Min Park, et al.. (2006). Polymorphisms in TGF-β1 gene and the risk of lung cancer. Lung Cancer. 52(1). 1–7. 53 indexed citations
19.
Park, Jae Hyung, Jung Min Park, Jung Min Park, et al.. (2006). Myeloperoxidase −463G>A polymorphism and risk of primary lung cancer in a Korean population. Cancer Detection and Prevention. 30(3). 257–261. 17 indexed citations
20.
Park, Jae Yong, et al.. (2006). Anisakiasis in Oral Cavity: A Case Report. 49(7). 763–765. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosario Caltabiano Breakdown of academic impact, for papers by Rafael López‐López Breakdown of academic impact, for papers by Shinya Kimura Breakdown of academic impact, for papers by Byeong‐Cheol Ahn Breakdown of academic impact, for papers by Corrado Rubini Breakdown of academic impact, for papers by Paavo Pääkkö Breakdown of academic impact, for papers by Andrea Nicolini Breakdown of academic impact, for papers by Roeland Hanemaaijer Breakdown of academic impact, for papers by Dongsheng Zhang Breakdown of academic impact, for papers by Pier Paolo Claudio
Rankless by CCL
2026